Blockchain Registration Transaction Record

Sandoz Capital Markets Day: Biosimilars’ Golden Decade

Sandoz hosts 2026 capital markets day on Sept 8 at London Stock Exchange, showcasing strategy for biosimilars growth. Includes live webcast and Slovenia site visit.

This news matters because Sandoz is a bellwether for the global generics and biosimilars industry, which directly affects healthcare costs and patient access to life-saving medications. The capital markets day will outline strategies that could lower drug prices, expand treatment options, and drive competition in the biosimilars market, potentially saving billions in healthcare spending. For investors, it offers a glimpse into Sandoz’s growth trajectory and financial outlook, impacting portfolio decisions. For patients, successful execution could mean more affordable biologics for chronic and complex diseases.